Andreas Christian Hocke - Infectious Diseases

Author Information

Andreas Christian Hocke is affiliated with the Department of Internal Medicine/Infectious Diseases and Respiratory Medicine at Charité - Universitätsmedizin Berlin, located in Berlin, Germany. His research primarily focuses on infectious diseases, with a special interest in the mechanisms of viral infections and their implications for respiratory health.

Research Contributions

Andreas Christian Hocke has made significant contributions to the field of infectious diseases, as evidenced by his extensive publication record. His recent work has focused on the COVID-19 pandemic, where he has explored various aspects of the disease, including autopsy studies, the formation of tertiary lymphoid structures in prolonged COVID-19, and the profibrotic responses triggered by SARS-CoV-2 infection. Additionally, his research extends to the study of viral replication advantages in different SARS-CoV-2 variants and the potential of host-targeting antivirals. Dr. Hocke's research also covers other areas such as bacteriophage therapy against bacterial lung infections and the impact of pneumolysin on lung epithelial cells.

Aliases

Andreas Christian Hocke has published under several aliases, including A. Hocke, Andreas C. Hocke, A. C. Hocke, and Andreas Hocke. These variations reflect the common practice of using abbreviated names in academic publications.

Publication and Citation Metrics

Metric	Value
Total Papers	192
Citation Count	9981
H-index	49

Publications:

Assessing and improving the validity of COVID-19 autopsy studies - a multi center approach to establish essential standards for immunohistochemical and ultrastructural analyses

DOI: 10.1101/2022.01.13.22269205

Year: 2022

Preclinical Testing of Dendritic Core-Multishell Nanoparticles in Inflammatory Skin Equivalents.

DOI: 10.1021/acs.molpharmaceut.1c00734

Year: 2022

Local CCL18 and CCL21 expand lung fibrovascular niches and recruit lymphocytes, leading to tertiary lymphoid structure formation in prolonged COVID-19

DOI: 10.1101/2022.03.24.22272768

Year: 2022

SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis

DOI: 10.1016/j.cell.2021.11.033

Year: 2021

Post-entry, spike-dependent replication advantage of B.1.1.7 and B.1.617.2 over B.1 SARS-CoV-2 in an ACE2-deficient human lung cell line

DOI: 10.1101/2021.10.20.465121

Year: 2021

SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals

DOI: 10.1038/s41467-021-24007-w

Year: 2021

Collapse induration of alveoli is an ultrastructural finding in a COVID-19 patient

DOI: 10.1183/13993003.04165-2020

Year: 2021

Morphological and molecular breast cancer profiling through explainable machine learning

DOI: 10.1038/S42256-021-00303-4

Year: 2021

Preclinical Assessment of Bacteriophage Therapy against Experimental Acinetobacter baumannii Lung Infection

DOI: 10.3390/v14010033

Year: 2021

Microvesicles released from pneumolysin-stimulated lung epithelial cells carry mitochondrial cargo and suppress neutrophil oxidative burst

DOI: 10.1038/s41598-021-88897-y

Year: 2021

Are There Risks Associated with Antipyretic Use?

What are the Challenges in Antimalarial Therapy?

What are the Symptoms of West Nile Virus?

How to Choose the Right Insect Repellent?

How Do Polymerase Inhibitors Work?

What are the Modes of Transmission?

What Preventive Measures Can Be Taken?

What Certifications are Necessary?

What is Chikungunya?

What are the Global Statistics on Infectious Disease Mortality?

Partnered Content Networks

Relevant Topics